Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 275 of 281 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/12/24
End: 05/08/24
Due: 05/08/25
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 02/25/23
Due: 02/25/24
Phase: N/A
Priority: Normal
Start: 09/10/22
End: 12/20/22
Due: 12/20/23
Phase: N/A
Priority: Normal
Start: 03/15/15
End: 02/04/16
Due: 02/04/17
Phase: N/A
Priority: Normal
Start: 05/05/24
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 05/20/22
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 11/09/17
End: 07/24/18
Due: 07/24/19
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 05/31/24
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 07/09/20
Due: 07/09/21
Phase: N/A
Priority: Normal
Start: 08/05/21
End: 07/31/22
Due: 07/31/23
Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 05/31/25
Due: 05/31/26
Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A
Phase: N/A
Priority: Normal
Start: 06/22/23
End: 06/21/24
Due: 06/21/25
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 12/16/21
End: 04/05/23
Due: 04/05/24
Phase: N/A
Priority: Normal
Start: 01/03/24
End: 03/27/24
Due: 03/27/25
Phase: N/A
Priority: Normal
Start: 03/21/22
End: 02/20/23
Due: 02/20/24
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 05/31/10
Due: 05/31/11